Cosimo Rasola

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases

Fotios Loupakis, Shruti Sharma, Madiha Derouazi et al. · JCO Precision Oncology · 2021 · 128 citations · Full text

Medicine, Clinical Sciences, Oncology +17

Phase II study of preoperative (PREOP) chemoradiotherapy (CTRT) plus avelumab (AVE) in patients (PTS) with locally advanced rectal cancer (LARC): The AVANA study.

Lisa Salvatore, Maria Bensi, Salvatore Corallo et al. · Journal of Clinical Oncology · 2021 · 67 citations

Medicine, Immunology, Oncology +17

Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO Foundation

Sara Lonardi, Cosimo Rasola, Riccardo Lobefaro et al. · Journal of Clinical Oncology · 2023 · 40 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Negative Ultraselection of Patients With <i>RAS</i>/<i>BRAF</i> Wild-Type, Microsatellite-Stable Metastatic Colorectal Cancer Receiving Anti–EGFR-Based Therapy

Giovanni Randon, Giulia Maddalena, Marco Maria Germani et al. · JCO Precision Oncology · 2022 · 30 citations · Full text

Medicine, Genetics, Oncology +17

Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal Cancer (mCRC) Patients Undergoing Surgical Resection

Sara Lonardi, Halla Nimeiri, Chang Xu et al. · International Journal of Molecular Sciences · 2022 · 23 citations · Full text

Medicine, Clinical Sciences, Oncology +17